BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16169119)

  • 1. Expression of oncostatin M and its receptors in normal and cirrhotic human liver.
    Znoyko I; Sohara N; Spicer SS; Trojanowska M; Reuben A
    J Hepatol; 2005 Nov; 43(5):893-900. PubMed ID: 16169119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
    Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
    Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture.
    Matthews VB; Knight B; Tirnitz-Parker JE; Boon J; Olynyk JK; Yeoh GC
    Exp Cell Res; 2005 May; 306(1):252-63. PubMed ID: 15878349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative).
    García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
    Cancer Invest; 2008; 26(3):222-9. PubMed ID: 18317962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells.
    Repovic P; Fears CY; Gladson CL; Benveniste EN
    Oncogene; 2003 Nov; 22(50):8117-24. PubMed ID: 14603252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M, a multifunctional cytokine.
    Tanaka M; Miyajima A
    Rev Physiol Biochem Pharmacol; 2003; 149():39-52. PubMed ID: 12811586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
    Underhill-Day N; Heath JK
    Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M and leukemia inhibitory factor regulate the growth of normal human breast epithelial cells.
    Grant SL; Douglas AM; Goss GA; Begley CG
    Growth Factors; 2001; 19(3):153-62. PubMed ID: 11811789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cartilage proteoglycan metabolism by LIF binding protein.
    Hui W; Bell MC; Carroll GJ; Layton MJ
    Cytokine; 1998 Mar; 10(3):220-6. PubMed ID: 9576068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence in human serum of a circulating soluble leukemia inhibitory factor receptor (sgp190) and its evolution during pregnancy.
    Pitard V; Lorgeot V; Taupin JL; Aubard Y; Praloran V; Moreau JF
    Eur Cytokine Netw; 1998 Dec; 9(4):599-605. PubMed ID: 9889403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia inhibitory factor contributes to hepatocyte-like differentiation of human bone marrow mesenchymal stem cells.
    Lysy PA; Smets F; Najimi M; Sokal EM
    Differentiation; 2008 Dec; 76(10):1057-67. PubMed ID: 18557762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncostatin M synergises with house dust mite proteases to induce the production of PGE(2) from cultured lung epithelial cells.
    Knight DA; Asokananthan N; Watkins DN; Misso NL; Thompson PJ; Stewart GA
    Br J Pharmacol; 2000 Oct; 131(3):465-72. PubMed ID: 11015296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.
    Ichihara M; Hara T; Kim H; Murate T; Miyajima A
    Blood; 1997 Jul; 90(1):165-73. PubMed ID: 9207450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell density-dependent regulation of hepatic development by a gp130-independent pathway.
    Kojima N; Kinoshita T; Kamiya A; Nakamura K; Nakashima K; Taga T; Miyajima A
    Biochem Biophys Res Commun; 2000 Oct; 277(1):152-8. PubMed ID: 11027656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M signaling in human glioma cell lines.
    Krona A; Järnum S; Salford LG; Widegren B; Aman P
    Oncol Rep; 2005 May; 13(5):807-11. PubMed ID: 15809742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.
    Kamiya A; Kinoshita T; Ito Y; Matsui T; Morikawa Y; Senba E; Nakashima K; Taga T; Yoshida K; Kishimoto T; Miyajima A
    EMBO J; 1999 Apr; 18(8):2127-36. PubMed ID: 10205167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
    Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
    J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal cytokine binding domain of LIFR is required for CNTF binding and signaling.
    He W; Gong K; Smith DK; Ip NY
    FEBS Lett; 2005 Aug; 579(20):4317-23. PubMed ID: 16051226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.